Asset
Afivastobart
Arcus Biosciences Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05891171 | phase1 | active_not_recruiting | 2023-10-13 | 2027-09-01 | Arcus Biosciences, Inc. | Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers |
FDA applications (0)
This company has no applications containing this asset.